Global Arteriotomy Closure Devices Market Forecast for 2020 to 2025

Lucida Medical (Cambridge University Spin-out) Joins GE Healthcare Edison™ Accelerator Programme

Lucida Medical was invited to join the Edison Accelerator programme for its pioneering work in helping identify prostate cancer and its exceptional development team led by Prof Evis Sala and Dr Antony Rix, both highly experienced in artificial intelligence, or AI, medical technology.

Boston Scientific Exercises Option to Acquire Farapulse, Inc.

FARAPULSE Pulsed Field Ablation (PFA) System is a non-thermal ablation system for the treatment of atrial fibrillation (AF) and other cardiac arrhythmias.  

October 21, 2020

Global Arteriotomy Closure Devices: The major factors attributing to the growth of the arteriotomy closure devices market are increasing incidences of vascular disorders and rising geriatric population.

The global increase in the incidence of vascular diseases is due to a sedentary lifestyle, unhealthy diet, and smoking. Cardiovascular diseases include coronary heart disease, stroke, high blood pressure, artery diseases, etc. According to the American Heart Association, in 2017, around 43% of the deaths occurs due to coronary heart disease in the United States. Manual compression has been considered the traditional technique to achieve closure of the arterial access site. Patient comfort and satisfaction are the important factors that result in wide adoption of arteriotomy closure devices.

Key Market Trends

Femoral Arterial Access is Highly Preferred in the Application Segment

The vast majority of procedures are performed with Femoral arterial access. However, increased interest has been observed for the radial approach due to the significant reduction in bleeding complications.

Vascular complications increase depending on the severity of the procedure. In order to reduce these complications, ACDs have been developed as an alternative to manual compression. The use of Arteriotomy Closure Devices is recommended to patients undergoing acute myocardial infarction, neurovascular interventions and endovascular procedures for peripheral vascular diseases. With the increasing incidence of vascular disorders as well as the development of innovative products, the growth of the market is expected to be augmented.

North America Dominates the Market and Expected to do same in the Forecast Period

North America will witness the highest growth throughout the forecast period. This is due to the increasing prevalence of lifestyle disease, rising aging population and growing demand for newly introduced devices and innovative technologies. According to American College of Cardiology’s National Cardiovascular Data Registry (ACC-NCDR, 2018), less than 2% of invasive cardiovascular procedures are performed from the radial site, which indicates that the common femoral artery remains the most common arterial access site in the United States. In the North America region, the United States holds the largest market share.

Key Topics Covered:

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Increasing Incidences of Vascular Disorders

4.2.2 Rising Geriatric Population

4.3 Market Restraints

4.3.1 High Cost of the Device

4.3.2 Risk Associated With the Procedure

4.4 Porter’s Five Force Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 By Products

5.1.1 Active Closure Devices

5.1.2 Passive Closure Devices

5.2 By Application

5.2.1 Femoral Arterial Access Procedures

5.2.2 Radial Arterial Access Procedures

5.3 By End User

5.3.1 Hospitals

5.3.2 Ambulatory Care Centers

5.3.3 Others

5.4 Geography

5.4.1 North America

5.4.1.1 United States

5.4.1.2 Canada

5.4.1.3 Mexico

5.4.2 Europe

5.4.2.1 Germany

5.4.2.2 United Kingdom

5.4.2.3 France

5.4.2.4 Italy

5.4.2.5 Spain

5.4.2.6 Rest of Europe

5.4.3 Asia-Pacific

5.4.3.1 China

5.4.3.2 Japan

5.4.3.3 India

5.4.3.4 Australia

5.4.3.5 South Korea

5.4.3.6 Rest of Asia-Pacific

5.4.4 Middle-East and Africa

5.4.4.1 GCC

5.4.4.2 South Africa

5.4.4.3 Rest of Middle-East and Africa

5.4.5 South America

5.4.5.1 Brazil

5.4.5.2 Argentina

5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 Abbott Laboratories

6.1.2 Cardinal Health

6.1.3 Cardiva Medical

6.1.4 Marine Polymer Technologies Inc

6.1.5 Medtronic PLC

6.1.6 Merit Medical

6.1.7 Teleflex Incorporated

6.1.8 Terumo Corporation

6.1.9 Vasorum Ltd

6.1.10 Vivasure Medical

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

More here.

spot_img

DON'T MISS

Trinity Health Names Mark LePage, M.D., as Senior Vice President of Medical Groups and Ambulatory Strategy

Prior to his time at IHA, LePage served as chief medical officer of Marshfield Clinic in Wisconsin

Jody Crane, MD Recognized by Modern Healthcare As One of the 50 Most Influential Clinical Executives

Dr. Crane’s work to streamline operations positioned and prepared TeamHealth and its clinicians to face the COVID-19 pandemic. Under Dr. Crane’s leadership, TeamHealth was able to maintain high levels of clinical quality throughout the rapidly changing COVID environment.

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

Subscribe to Medical Device News Magazine here.

Related Articles